Hematology/Oncology

Top Story

Patients with RA may be at greater risk for developing lung cancer, lymphoma

August 31, 2015

Patients with rheumatoid arthritis may have a higher risk for developing lung cancer or lymphoma compared with the general population but may be at lower risk for certain other malignancies, according to the results of a meta-analysis.

Researchers identified 136 studies that included rheumatoid arthritis (RA) and a variety of terminology related to malignancies. Inclusion criteria were studies that involved an observational design, malignancy outcomes in patients with RA and included only patients over 18 years of age.

FDA News

FDA grants priority review to MCNA for nonmuscle-invasive bladder cancer

August 31, 2015
The FDA granted priority review to MCNA for patients with high-risk nonmuscle-invasive bladder cancer, according to a press release from the drug’s…
David M. Gershenson, MD In the Journals

Younger age predicts worse survival from low-grade serous carcinoma of ovary, peritoneum

August 31, 2015
Women aged 35 or younger with low-grade serous carcinoma of the ovary or the peritoneum, as well as those with persistent disease upon therapy completion, have worse…
Mikkael A. Sekeres In the Journals

ED interventions reduce time to treatment of febrile neutropenia

August 31, 2015
The implementation of an intervention pathway reduced the time to administration of necessary antibiotics in the emergency department among adult patients with cancer…
In the Journals

Readmission rates may skew hospital quality measurements

August 31, 2015
Readmission rates were an ineffective measure of a hospital’s quality because they did not take into account readmissions from different hospitals, resulting in a…
More News Headlines »
CME
Hematology Oncology Case Consults

The Patient with Chronic Lymphocytic Leukemia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with chronic lymphocytic leukemia.
More »
Meeting News Coverage Video
VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

August 20, 2015
CHICAGO — The PALOMA-3 trial, which evaluated the addition of palbociclib to fulvestrant, demonstrated…
More »
CME
Updates in Immunotherapy – Philadelphia 2015

Updates in Immunotherapy – Philadelphia 2015

This activity is supported by an educational grant from Merck & Co., Inc.

The promise of immunotherapy in oncology has become a reality with the US Food and Drug Administration (FDA) approval…
More »